Literature DB >> 1313068

Effect of high-dose dexamethasone on the outcome of acute encephalitis due to Japanese encephalitis virus.

C H Hoke1, D W Vaughn, A Nisalak, P Intralawan, S Poolsuppasit, V Jongsawas, U Titsyakorn, R T Johnson.   

Abstract

Death due to Japanese encephalitis usually occurs in the first 5 days of hospitalization as a result of deepening coma with respiratory arrest. Death may result from edema-induced increases in intracranial pressure that might be reduced by the administration of steroids. Sixty-five patients presenting in Thailand to four hospitals with a diagnosis of acute Japanese encephalitis were randomized in a double-masked fashion and stratified by initial mental status into a placebo group (saline) or a treatment group (dexamethasone 0.6 mg/kg intravenously as a loading dose followed by 0.2 mg/kg every 6 h for 5 days). Fifty-five of the 65 had confirmed Japanese encephalitis as demonstrated by detection of virus or by Japanese encephalitis virus-specific IgM antibody. Important outcome measures included mortality (24%, treatment group; 27%, control group), days to alert mental status (3.9 vs. 6.2), and neurologic status 3 months after discharge (45% abnormal in each group). No statistically significant benefit of high-dose dexamethasone could be detected.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313068     DOI: 10.1093/infdis/165.4.631

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Japanese encephalitis.

Authors:  T Solomon; N M Dung; R Kneen; M Gainsborough; D W Vaughn; V T Khanh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

Review 2.  Perspectives for the treatment of infections with Flaviviridae.

Authors:  P Leyssen; E De Clercq; J Neyts
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

3.  Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics.

Authors:  N B S Sarkari; A K Thacker; S P Barthwal; V K Mishra; Shiv Prapann; Deepak Srivastava; M Sarkari
Journal:  J Neurol       Date:  2011-06-17       Impact factor: 4.849

4.  Coexistent neurocysticercosis and Japanese B encephalitis: MR imaging correlation.

Authors:  P Singh; N Kalra; R K Ratho; S Shankar; N Khandelwal; S Suri
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

5.  Viral encephalitis of public health significance in India: current status.

Authors:  R Kumar
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

6.  Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections.

Authors:  A J Cuzzubbo; T P Endy; D W Vaughn; T Solomon; A Nisalak; S Kalayanarooj; N M Dung; D Warrilow; J Aaskov; P L Devine
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

7.  Comparison of PanBio dengue duo enzyme-linked immunosorbent assay (ELISA) and MRL dengue fever virus immunoglobulin M capture ELISA for diagnosis of dengue virus infections in Southeast Asia.

Authors:  A J Cuzzubbo; D W Vaughn; A Nisalak; T Solomon; S Kalayanarooj; J Aaskov; N M Dung; P L Devine
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

Review 8.  Japanese viral encephalitis.

Authors:  S V Tiroumourougane; P Raghava; S Srinivasan
Journal:  Postgrad Med J       Date:  2002-04       Impact factor: 2.401

Review 9.  West Nile virus encephalitis in the United States.

Authors:  Richard T Johnson; David N Irani
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

10.  Japanese Encephalitis Vaccines.

Authors:  Monica A McArthur; Michael R Holbrook
Journal:  J Bioterror Biodef       Date:  2011-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.